A drug commonly used to treat diabetes could help those living with Parkinson’s disease, research has revealed, according to The Guardian.
Researchers believe that medicines used to treat diabetes could also be used to combat Alzheimer's disease and vice versa, after a new study showed the very close relationship between the two conditions, according to PharmaTimes online
A study for the Sue Ryder charity reports over two-thirds of the public say they had no, or very little knowledge, of neurological disorders according to an article in The Guardian.
"Vital clues about how the brain erases long-term memories have been uncovered by Scottish researchers pointing towards new ways of tackling conditions such as Alzheimer’s disease and other causes of dementia," according to The Scotman
On CareKnowledge, this report marks the start of a new Alzheimer’s Society campaign looking at the experiences of people affected by dementia in a range of health and care settings. It contains the results of Freedom of Information requests from hospital trusts across England.
Alzheimer’s drug prescriptions six times higher than decade ago, new figures show, according to Mental Health Today.
Common dementia drug found to improve Parkinson’s symptoms - see article on ITV News website.
Charity chief hails progress in the fight to find a cure for Huntingdon's disease (HE) - an article in The Herald
Moderate coffee drinking may be tied to lower risk of death. Article on Reuters website.
Withdrawing a common Alzheimer’s drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, research from University College London (UCL) revealed, according to Nursing in Practice.
First human trial for innovative new drug in development to treat Huntington’s disease from University College London news.
The woman who can smell Parkinson's Disease - from the BBC website.
A study reported in Mental Health Today found inflammation in the brain linked to risk of schizophrenia.
News articles from the National Institute of Neurological Disorders and Stroke